- Home
- VNET vs SPRY Comparison
VNET vs SPRY Comparison
Compare VNET & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNET
- SPRY
- Stock Information
- Founded
- VNET 1999
- SPRY 2015
- Country
- VNET China
- SPRY United States
- Employees
- VNET N/A
- SPRY N/A
- Industry
- VNET Computer Software: Programming Data Processing
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- VNET Technology
- SPRY Health Care
- Exchange
- VNET Nasdaq
- SPRY Nasdaq
- Market Cap
- VNET 2.2B
- SPRY 1.8B
- IPO Year
- VNET 2011
- SPRY N/A
- Fundamental
- Price
- VNET $8.29
- SPRY $13.50
- Analyst Decision
- VNET Strong Buy
- SPRY Strong Buy
- Analyst Count
- VNET 4
- SPRY 4
- Target Price
- VNET $11.20
- SPRY $28.75
- AVG Volume (30 Days)
- VNET 4.9M
- SPRY 1.8M
- Earning Date
- VNET 08-21-2025
- SPRY 08-13-2025
- Dividend Yield
- VNET N/A
- SPRY N/A
- EPS Growth
- VNET N/A
- SPRY N/A
- EPS
- VNET N/A
- SPRY N/A
- Revenue
- VNET $1,262,962,115.00
- SPRY $112,339,000.00
- Revenue This Year
- VNET $15.46
- SPRY N/A
- Revenue Next Year
- VNET $20.35
- SPRY $170.64
- P/E Ratio
- VNET $385.17
- SPRY N/A
- Revenue Growth
- VNET 17.85
- SPRY 22367.80
- 52 Week Low
- VNET $1.85
- SPRY $10.00
- 52 Week High
- VNET $16.13
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- VNET 55.84
- SPRY 31.35
- Support Level
- VNET $7.27
- SPRY $13.51
- Resistance Level
- VNET $8.30
- SPRY $15.09
- Average True Range (ATR)
- VNET 0.51
- SPRY 1.03
- MACD
- VNET -0.05
- SPRY -0.33
- Stochastic Oscillator
- VNET 70.10
- SPRY 0.99
About VNET VNET Group Inc.
VNET started as AsiaCloud in 1999 and moved to the data center business with its first self-developed data center opening in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of March 2025, it had 51,960 retail cabinets with the majority in Beijing, Shanghai, and the Greater Bay area. It also had 573 MW of wholesale capacity in service with a further 377 MW under construction and a further 670 MW held for future development.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.